Commercial / Business development executive with a background in drug discovery research, process and product development focused on complex cellular and tissue models, pathway biology, novel discovery and experience translating results into the clinic. Extensive deal book with key contacts in biotech and pharma.   Development of iPSC-derived products and processes to support commercial testing services focused on drug discovery, pre-clinical toxicology and rare-disease research and complex disease models.  Development and application expertise in uHTS, primary cell and tissue models, target identification and cellular profiling including automated assay development for biochemical, cell based and immunologic assays.